Immunocore IMCR
$26.41 −$0.22 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.41 0.00%
Open$26.37
Prev close$26.63
Day range$25.61 – $26.82
Volume546.2K
Market cap$1.36B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$102.22M-1.4% YoY
Operating profit-$13.61M-89.8% YoY
Net profit-$14.22M-7,935.0% YoY
Diluted EPS-$0.28
Free cash flow$17.74M+441.0% YoY
Operating cash flow$20.09M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin98.9%
Operating margin-6.8%
Net margin-7.5%
Return on equity-7.9%
Return on assets-2.9%
Return on invested capital-4.0%
Current ratio4.62
Liabilities / assets62.8%
Cash & investments$901.30M
Total debt$433.97M
Net cash (debt)$467.33M
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $102.22M | $115.93M | $106.68M | $400.02M | $104.48M |
| Total Operating Revenue | $102.22M | $115.93M | $106.68M | $400.02M | $104.48M |
| Cost of Revenue | $676,000.00 | $1.09M | $434,000.00 | $5.09M | $2.70M |
| Gross Profit | $101.55M | $114.84M | $106.24M | $394.93M | $101.78M |
| Operating Expense | $115.16M | $117.84M | $98.96M | $440.28M | $121.47M |
| Selling and Admin Expenses | $40.45M | $43.89M | $37.85M | $165.41M | $42.65M |
| Research & Development | $74.70M | $73.95M | $61.11M | $274.87M | $78.82M |
| Operating Profit | -$13.61M | -$3.00M | $7.28M | -$45.35M | -$19.69M |
| Net Non-Operating Interest Income (Expense) | $547,000.00 | $520,000.00 | $367,000.00 | $4.31M | $853,000.00 |
| Non-Operating Interest Income | $3.61M | $3.58M | $3.42M | $16.48M | $3.91M |
| Non-Operating Interest Expense | $2.52M | $2.52M | $3.05M | $12.17M | $4.62M |
| Total Other Finance Costs | $543,000.00 | $547,000.00 | – | – | – |
| Other Income (Expense) | -$1.01M | $1.96M | $5.63M | $21.94M | $3.04M |
| Gain on Sale of Security | -$1.77M | -$1.11M | $3.85M | $2.22M | -$1.46M |
| Other Non-Operating Income (Expenses) | $763,000.00 | $3.07M | $1.78M | $19.73M | $4.50M |
| Pretax Profit | -$14.07M | -$514,000.00 | $13.27M | -$19.10M | -$15.79M |
| Tax | $153,000.00 | $294,000.00 | $301,000.00 | $16.41M | $14.27M |
| Net Profit | -$14.22M | -$808,000.00 | $12.97M | -$35.51M | -$30.06M |
| Profit from Continuing Operations | -$14.22M | -$808,000.00 | $12.97M | -$35.51M | -$30.06M |
| Net Income to Parent Company | -$14.22M | -$808,000.00 | $12.97M | -$35.51M | -$30.06M |
| Net Income to Common Stockholders | -$14.22M | -$808,000.00 | $12.97M | -$35.51M | -$30.06M |
| Basic EPS | -$0.28 | -$0.02 | $0.26 | -$0.71 | -$0.60 |
| Diluted EPS | -$0.28 | -$0.02 | $0.25 | -$0.71 | -$0.60 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.13B | $1.12B | $1.07B | $1.07B | $1.07B |
| Total Current Assets | $1.06B | $1.05B | $1.00B | $996.74M | $996.74M |
| Cash and Cash Equivalents & Short-Term Investments | $901.30M | $880.21M | $844.90M | $864.15M | $864.15M |
| -Cash and Cash Equivalents | $512.25M | $484.92M | $452.68M | $467.71M | $467.71M |
| -Short Term Investments | $389.05M | $395.29M | $392.22M | $396.44M | $396.44M |
| Receivables | $88.03M | $95.35M | $81.07M | $101.12M | $101.12M |
| -Accounts Receivable | $88.03M | $95.35M | $81.07M | $73.98M | $73.98M |
| Inventory | $7.47M | $7.79M | $8.25M | $6.74M | $6.74M |
| Other Current Assets | $63.64M | $67.69M | $69.59M | $6.75M | $6.75M |
| Total Non-Current Assets | $68.81M | $68.38M | $68.29M | $70.53M | $70.53M |
| Net PPE | $50.33M | $49.88M | $49.67M | $50.25M | $50.25M |
| -Gross PPE | $50.33M | $49.88M | $49.67M | $111.05M | $111.05M |
| Other Non-Current Assets | $18.48M | $18.50M | $18.61M | $20.28M | $20.28M |
| Total Liabilities | $709.53M | $699.62M | $678.42M | $686.24M | $686.24M |
| Total Current Liabilities | $229.62M | $235.20M | $240.11M | $246.70M | $246.70M |
| Payables | $21.39M | $26.32M | $30.16M | $24.36M | $24.36M |
| -Accounts Payable | $21.39M | $26.32M | $30.16M | $24.36M | $24.36M |
| Current Accrued Expenses | $193.37M | $197.27M | $202.16M | $203.20M | $203.20M |
| Short-Term Debt and Capital Lease Obligation | $1.77M | $1.91M | $2.00M | $2.01M | $2.01M |
| -Current Capital Lease Obligation | $1.77M | $1.91M | $2.00M | $2.01M | $2.01M |
| Current Deferred Liabilities | $573,000.00 | $573,000.00 | $572,000.00 | $583,000.00 | $583,000.00 |
| Total Non-Current Liabilities | $479.91M | $464.43M | $438.31M | $439.54M | $439.54M |
| Non-Current Accrued Expenses | $41.60M | $26.88M | – | – | – |
| Long Term Debt and Capital Lease Obligation | $433.97M | $433.05M | $433.69M | $434.68M | $434.68M |
| -Long Term Debt | $394.75M | $394.21M | $393.66M | $393.13M | $393.13M |
| -Long Term Capital Lease Obligation | $39.22M | $38.85M | $40.03M | $41.56M | $41.56M |
| Non-Current Deferred Liabilities | $4.34M | $4.49M | $4.62M | $4.86M | $4.86M |
| Total Equity | $419.71M | $419.80M | $393.67M | $381.03M | $381.03M |
| Stockholders' Equity | $419.71M | $419.80M | $393.67M | $381.03M | $381.03M |
| Capital Stock | $139,000.00 | $138,000.00 | $137,000.00 | $136,000.00 | $136,000.00 |
| -Common Stock | $139,000.00 | $138,000.00 | $137,000.00 | $136,000.00 | $136,000.00 |
| Additional Paid-In Capital | $1.29B | $1.27B | $1.25B | $1.24B | $1.24B |
| Retained Earnings | -$833.33M | -$819.11M | -$818.30M | -$831.28M | -$831.28M |
| Gains/Losses Not Affecting Retained Earnings | -$33.68M | -$34.33M | -$35.37M | -$28.08M | -$28.08M |
| Other Equity Interests | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -Taxes Receivable | – | – | – | $27.14M | $27.14M |
| Prepaid Assets | – | – | – | $17.98M | $17.98M |
| -Accumulated Depreciation | – | – | – | -$60.80M | -$60.80M |
| Non-Current Deferred Assets | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $20.09M | $15.93M | -$13.78M | -$10.71M | -$32.66M |
| Net cash flow from continuing operations | $20.09M | $15.93M | -$13.78M | -$10.71M | -$32.66M |
| Net Income from Continuing Operations | -$14.22M | -$808,000.00 | $12.97M | -$35.51M | -$30.06M |
| Gain/Loss from Continuing Operations | $1.26M | $808,000.00 | -$3.49M | -$6.39M | $3.84M |
| Depreciation & Depletion & Amortization | $1.11M | $1.03M | $948,000.00 | $3.27M | $834,000.00 |
| Other Non-Cash Items | $1.20M | $1.16M | $1.16M | $4.46M | $1.20M |
| Change in Working Capital | $21.78M | $7.41M | -$29.89M | -$9.30M | -$27.10M |
| -Change in Receivables | $6.75M | -$14.62M | -$7.93M | -$7.34M | $1.99M |
| -Change in Prepaid Assets | $3.88M | $2.10M | -$18.77M | -$6.74M | -$1.02M |
| -Change in Payables and Accrued Expense | $10.41M | $22.20M | -$2.33M | $13.43M | -$20.61M |
| -Change in Other Current Assets | $637,000.00 | -$755,000.00 | $150,000.00 | -$6.18M | -$4.71M |
| -Change in Other Current Liabilities | $246,000.00 | -$1.36M | -$864,000.00 | -$2.09M | -$2.62M |
| -Change In Other Working Capital | -$144,000.00 | -$146,000.00 | -$146,000.00 | -$387,000.00 | -$144,000.00 |
| Net cash flow from investing | $4.65M | -$786,000.00 | $4.22M | -$16.34M | -$880,000.00 |
| Net Cash Flow from Continuing Investing Activities | $4.65M | -$786,000.00 | $4.22M | -$16.34M | -$880,000.00 |
| Net PPE Purchase and Sale | -$2.35M | -$786,000.00 | -$1.78M | -$4.34M | -$2.88M |
| Net Investment Purchase and Sale | $7.00M | $0.00 | $6.00M | -$12.00M | $2.00M |
| Financing Cash Flow | $3.76M | $16.49M | $656,000.00 | $12.37M | $4.28M |
| Net Cash Flow from Continuing Financing Activities | $3.76M | $16.49M | $656,000.00 | $12.37M | $4.28M |
| Proceeds from Stock Option Exercised | $3.76M | $16.49M | $656,000.00 | $12.37M | $4.28M |
| Ending Cash Balance | $512.25M | $484.92M | $452.68M | $467.71M | $467.71M |
| Net Change in Cash | $28.50M | $31.63M | -$8.90M | -$14.68M | -$29.25M |
| Beginning Cash Balance | $484.92M | $452.68M | $467.71M | $455.73M | $498.41M |
| Effect of Exchange Rate Changes | -$1.17M | $618,000.00 | -$6.13M | $26.66M | -$1.45M |
| Free Cash Flow | $17.74M | $15.14M | -$15.56M | -$15.05M | -$35.54M |
| Deferred Tax | – | – | – | $14.79M | – |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on IMCR.
Sign in to join the discussion.